Johns Hopkins University

Tula Raghavan

Henry Brem

Betty M Tyler

Antonella Mangraviti

Alessandro Olivi

Local delivery formulations of the antineoplastic and microbicide agent acriflavine, and methods of making and using thereof are significantly more efficacious at increasing the median survival of subjects with proliferative disease than systemic administrations of acriflavine. The local delivery formulations of acriflavine show a dose-dependent increase in the median survival of subjects. The local delivery forms provide the increased efficacy without the toxicity associated with systemic administration of the agent.

Growing community of inventors

Baltimore, MD, United States of America

Tula Raghavan